Purchases and Sales Made in Q4 2023 in Biondvax Pharmaceuticals Ltd. (BVXVZZZZ)
This table provides information about the institutional ownership of Biondvax Pharmaceuticals Ltd. (BVXVZZZZ) during Q4 2023. The information is specifically focused on institutions that hold shares of BIONDVAX PHARMACEUTICALS LTD. .
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Aug 16, 2024
Q4 2023
|
Morgan Stanley
New York, NY |
BUY
|
- |
2.58KNew |
N/A
|
2.58K
$0
|
|
|
Feb 08, 2024
Q4 2023
|
Rhumbline Advisers
Boston, MA |
BUY
|
- |
1.77K+ 49.73% |
N/A
|
5.31K
$0
|
|
|
Feb 09, 2024
Q4 2023
|
Ubs Group Ag
|
BUY
|
- |
1.29K+ 156.92% |
N/A
|
2.12K
$0
|
|
|
Feb 13, 2024
Q4 2023
|
Credit Agricole S A
|
BUY
|
- |
424New |
N/A
|
424
$0
|
|
|
Feb 13, 2024
Q4 2023
|
Morgan Stanley
New York, NY |
BUY
|
- |
300+ 13.15% |
N/A
|
2.58K
$0
|
|
|
Feb 15, 2024
Q4 2023
|
Main Street Group, LTD
Glen Allen, VA |
BUY
|
- |
200New |
N/A
|
200
$0
|
|
|
Feb 07, 2024
Q4 2023
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
N/A
|
0
$0
|
|
|
Feb 14, 2024
Q4 2023
|
Sabby Management, LLC
Upper Saddle River, NJ |
SELL
|
- |
-24.3K- 9.92% |
N/A
|
221K
$0
|
|
|
Feb 13, 2024
Q4 2023
|
Armistice Capital, LLC
New York, NY |
SELL
|
- |
-132K- 36.3% |
N/A
|
231K
$0
|